In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 21461-84-7, name is (S)-( )-5-Oxo-2-tetrahydrofurancarboxylic Acid, introducing its new discovery. Formula: C5H6O4
Disclosed is an optically active compound represented by the formula: STR1 wherein R1 and R2 are alkyl, alkenyl or alkoxy-alkyl, which may be substituted by halogen, X and U are a direct bond, –O–, –COO– or –OCO–, Y and Z are a direct bond, –COO–, –OCO–, –CH2 O– or –OCH2 –, A1 and A2 are phenylene, cyclohexylene or a phenylene- or cyclohexylene-containing group, p and q are 0 or 1, C* is an asymmetric carbon atom, with the proviso that when Z is a direct bond, q is 0, R2 is alkyl, Y is a direct bond, –OCO– or –OCH2 –. The optically active compound is used as a ferroelectric liquid crystal or an additive to a ferroelectric or non-ferroelectric liquid crystal.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 21461-84-7, and how the biochemistry of the body works.Formula: C5H6O4
Reference：
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem